Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. It occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread (metastasize) from the prostate to other parts of the body, especially the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, erectile dysfunction and other symptoms.This cancer can occur only in men, as the prostate gland is found only in the male reproductive tract. It is one of the most common types of cancer in men.

PROSTATE CANCER incidence

The term 'prevalence' of Prostate Cancer usually refers to the estimated population of people who are managing Prostate Cancer at any given time. The term 'incidence' of Prostate Cancer refers to the annual diagnosis rate, or the number of new cases of Prostate Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence.

Prostate cancer incidence statistics for men in various countries:
112.3 men per 100,000 population with prostate cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
80.2 men per 100,000 population with prostate cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
63 men per 100,000 population with prostate cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
42.2 men per 100,000 population with prostate cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
39.6 men per 100,000 population with prostate cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
32 men per 100,000 population with prostate cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
29.9 men per 100,000 population with prostate cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
22.2 men per 100,000 population with prostate cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
13.9 men per 100,000 population with prostate cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
9.0 men per 100,000 population with prostate cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
8.6 men per 100,000 population with prostate cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
7.4 men per 100,000 population with prostate cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)